194 related articles for article (PubMed ID: 3124297)
21. Fractionation of red diamond rattlesnake (Crotalus ruber ruber) venom: protease, phosphodiesterase, L-amino acid oxidase activities and effects of metal ions and inhibitors on protease activity.
Mackessy SP
Toxicon; 1985; 23(2):337-40. PubMed ID: 2992122
[TBL] [Abstract][Full Text] [Related]
22. Neutralization of edema, hemorrhage and myonecrosis induced by North American crotalid venoms in simulated first-aid treatments.
Evans J; Ownby CL
Toxicon; 1999 Apr; 37(4):633-50. PubMed ID: 10082163
[TBL] [Abstract][Full Text] [Related]
23. In vivo ability of antimyotoxin a serum plus polyvalent (Crotalidae) antivenom to neutralize prairie rattlesnake (Crotalus viridis viridis) venom.
Ownby CL; Colberg TR; Odell GV
Toxicon; 1986; 24(2):197-200. PubMed ID: 3705096
[TBL] [Abstract][Full Text] [Related]
24. Neutralization of venoms from two Southern Pacific Rattlesnakes (Crotalus helleri) with commercial antivenoms and endothermic animal sera.
Galán JA; Sánchez EE; Rodríguez-Acosta A; Pérez JC
Toxicon; 2004 Jun; 43(7):791-9. PubMed ID: 15284013
[TBL] [Abstract][Full Text] [Related]
25. Venom properties of the rattlesnakes (Crotalus) inhabiting the Baja California region of Mexico.
Glenn JL; Straight RC
Toxicon; 1985; 23(5):769-75. PubMed ID: 3003969
[TBL] [Abstract][Full Text] [Related]
26. Hypotensive and hemostatic properties of rattlesnake (Crotalus viridis helleri) venom and venom fractions in dogs.
Schaeffer RC; Briston C; Chilton SM; Carlson RW
J Pharmacol Exp Ther; 1984 Aug; 230(2):393-8. PubMed ID: 6747842
[TBL] [Abstract][Full Text] [Related]
27. Purification and biochemical study of viriditoxin, tissue damaging toxin, from prairie rattlesnake venom.
Fabiano RJ; Tu AT
Biochemistry; 1981 Jan; 20(1):21-7. PubMed ID: 6781535
[TBL] [Abstract][Full Text] [Related]
28. Isolation of two phospholipases A2 from Mojave rattlesnake (Crotalus scutulatus scutulatus) venom and variation of immunologically related venom proteins in different populations.
Zepeda H; Rael ED; Knight RA
Comp Biochem Physiol B; 1985; 81(2):319-24. PubMed ID: 3926375
[TBL] [Abstract][Full Text] [Related]
29. Geographic and ontogenic variability in the venom of the neotropical rattlesnake Crotalus durissus: pathophysiological and therapeutic implications.
Saravia P; Rojas E; Arce V; Guevara C; López JC; Chaves E; Velásquez R; Rojas G; Gutiérrez JM
Rev Biol Trop; 2002 Mar; 50(1):337-46. PubMed ID: 12298262
[TBL] [Abstract][Full Text] [Related]
30. A crotoxin homolog from the venom of the Uracoan rattlesnake (Crotalus vegrandis).
Kaiser II; Aird SD
Toxicon; 1987; 25(10):1113-20. PubMed ID: 3122371
[TBL] [Abstract][Full Text] [Related]
31. Intraspecific venom variation in the medically significant Southern Pacific Rattlesnake (Crotalus oreganus helleri): biodiscovery, clinical and evolutionary implications.
Sunagar K; Undheim EA; Scheib H; Gren EC; Cochran C; Person CE; Koludarov I; Kelln W; Hayes WK; King GF; Antunes A; Fry BG
J Proteomics; 2014 Mar; 99():68-83. PubMed ID: 24463169
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of the biological activities of rattlesnake (genera Crotalus and Sistrurus) venoms.
Tan NH; Ponnudurai G
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 98(2-3):455-61. PubMed ID: 1676959
[TBL] [Abstract][Full Text] [Related]
33. Comparison of venom composition and biological activities of the subspecies Crotalus lepidus lepidus, Crotalus lepidus klauberi and Crotalus lepidus morulus from Mexico.
Martínez-Romero G; Rucavado A; Lazcano D; Gutiérrez JM; Borja M; Lomonte B; Garza-García Y; Zugasti-Cruz A
Toxicon; 2013 Sep; 71():84-95. PubMed ID: 23732126
[TBL] [Abstract][Full Text] [Related]
34. A novel phospholipase A2 (D49) from the venom of the Crotalus oreganus abyssus (North American Grand canyon rattlesnake).
Martins W; Baldasso PA; Honório KM; Maltarollo VG; Ribeiro RI; Carvalho BM; Soares AM; Calderon LA; Stábeli RG; Caballol MA; Acosta G; Oliveira E; Marangoni S; Albericio F; Da Silva SL
Biomed Res Int; 2014; 2014():654170. PubMed ID: 24707493
[TBL] [Abstract][Full Text] [Related]
35. Disintegrin, hemorrhagic, and proteolytic activities of Mohave rattlesnake, Crotalus scutulatus scutulatus venoms lacking Mojave toxin.
Sánchez EE; Galán JA; Powell RL; Reyes SR; Soto JG; Russell WK; Russell DH; Pérez JC
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Jun; 141(2):124-32. PubMed ID: 16005687
[TBL] [Abstract][Full Text] [Related]
36. Partial characterization of a basic protein from Crotalus molossus molossus (northern blacktail rattlesnake) venom and production of a monoclonal antibody.
Sánchez EE; Soliz LA; Ramírez MS; Pérez JC
Toxicon; 2001 Apr; 39(4):523-37. PubMed ID: 11024493
[TBL] [Abstract][Full Text] [Related]
37. Ability of antiserum to myotoxin alpha from prairie rattlesnake (Crotalus viridis viridis) venom to neutralize local myotoxicity and lethal effects of myotoxin alpha and homologous crude venom.
Ownby CL; Odell GV; Woods WM; Colberg TR
Toxicon; 1983; 21(1):35-45. PubMed ID: 6845385
[No Abstract] [Full Text] [Related]
38. Venom Ontogeny in the Mexican Lance-Headed Rattlesnake (
Mackessy SP; Leroy J; Mociño-Deloya E; Setser K; Bryson RW; Saviola AJ
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29970805
[TBL] [Abstract][Full Text] [Related]
39. Geographic and ontogenic variation in venom of the western diamondback rattlesnake (Crotalus atrox).
Minton SA; Weinstein SA
Toxicon; 1986; 24(1):71-80. PubMed ID: 3513378
[TBL] [Abstract][Full Text] [Related]
40. Protease activity and lethal toxicity of venoms from some little known rattlesnakes.
Minton SA; Weinstein SA
Toxicon; 1984; 22(5):828-30. PubMed ID: 6395444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
